The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
122127445 12212744 5 F 20160314 20160721 20160328 20160725 EXP DE-ROCHE-1731505 ROCHE 69.00 YR M Y 77.00000 KG 20160725 MD DE DE

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
122127445 12212744 1 PS Bevacizumab BEVACIZUMAB 1 Intravenous (not otherwise specified) Y 125085 385 MG SOLUTION FOR INFUSION QOW
122127445 12212744 2 SS Bevacizumab BEVACIZUMAB 1 Intravenous (not otherwise specified) LAST DOSE PRIOR TO SAE Y 125085 308 MG SOLUTION FOR INFUSION QOW
122127445 12212744 3 C FOLINIC ACID LEUCOVORIN 1 Intravenous (not otherwise specified) 0 780 MG /wk
122127445 12212744 4 C FOLINIC ACID LEUCOVORIN 1 Intravenous (not otherwise specified) 0 624 MG QOW
122127445 12212744 5 C FOLINIC ACID LEUCOVORIN 1 Intravenous (not otherwise specified) 0 624 MG QOW
122127445 12212744 6 C FOLINIC ACID LEUCOVORIN 1 Intravenous (not otherwise specified) 0 624 MG QOW
122127445 12212744 7 C FOLINIC ACID LEUCOVORIN 1 Intravenous (not otherwise specified) 0 624 MG QOW
122127445 12212744 8 C FOLINIC ACID LEUCOVORIN 1 Intravenous (not otherwise specified) 0 624 MG QOW
122127445 12212744 9 C 5-FU FLUOROURACIL 1 Intravenous bolus 0 780 MG QOW
122127445 12212744 10 C 5-FU FLUOROURACIL 1 Intravenous drip 0 2340 MG QOW
122127445 12212744 11 C 5-FU FLUOROURACIL 1 Intravenous bolus 0 624 MG QOW
122127445 12212744 12 C 5-FU FLUOROURACIL 1 Intravenous drip 0 1872 MG QOW
122127445 12212744 13 C 5-FU FLUOROURACIL 1 Intravenous bolus 0 624 MG QOW
122127445 12212744 14 C 5-FU FLUOROURACIL 1 Intravenous bolus 0 624 MG QOW
122127445 12212744 15 C 5-FU FLUOROURACIL 1 Intravenous bolus 0 624 MG QOW
122127445 12212744 16 C 5-FU FLUOROURACIL 1 Intravenous bolus 0 624 MG QOW
122127445 12212744 17 C 5-FU FLUOROURACIL 1 Intravenous drip 0 1872 MG QOW
122127445 12212744 18 C 5-FU FLUOROURACIL 1 Intravenous drip 0 1872 MG QOW
122127445 12212744 19 C 5-FU FLUOROURACIL 1 Intravenous drip 0 1872 MG QOW
122127445 12212744 20 C 5-FU FLUOROURACIL 1 Intravenous drip 0 1872 MG QOW
122127445 12212744 21 C IRINOTECAN IRINOTECAN 1 Intravenous (not otherwise specified) 0 350 MG QOW
122127445 12212744 22 C IRINOTECAN IRINOTECAN 1 Intravenous (not otherwise specified) 0 280 MG QOW
122127445 12212744 23 C IRINOTECAN IRINOTECAN 1 Intravenous (not otherwise specified) 0 280 MG QOW
122127445 12212744 24 C IRINOTECAN IRINOTECAN 1 Intravenous (not otherwise specified) 0 280 MG QOW
122127445 12212744 25 C IRINOTECAN IRINOTECAN 1 Intravenous (not otherwise specified) 0 280 MG QOW
122127445 12212744 26 C IRINOTECAN IRINOTECAN 1 Intravenous (not otherwise specified) 0 280 MG QOW

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
122127445 12212744 1 Colorectal cancer
122127445 12212744 3 Colorectal cancer
122127445 12212744 9 Colorectal cancer
122127445 12212744 21 Colorectal cancer

Outcome of event

Event ID CASEID OUTC COD
122127445 12212744 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
122127445 12212744 Decreased appetite
122127445 12212744 Diarrhoea
122127445 12212744 Fungal infection
122127445 12212744 General physical health deterioration
122127445 12212744 Monoparesis
122127445 12212744 Pain
122127445 12212744 Prerenal failure
122127445 12212744 Weight decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
122127445 12212744 1 20160314 0
122127445 12212744 2 20160608 0
122127445 12212744 3 20160314 20160314 0
122127445 12212744 4 20160413 0
122127445 12212744 5 20140427 20140427 0
122127445 12212744 6 20160511 20160511 0
122127445 12212744 7 20160525 20160525 0
122127445 12212744 8 20160608 20160608 0
122127445 12212744 9 20160314 20160314 0
122127445 12212744 10 20160314 20160316 0
122127445 12212744 11 20160413 0
122127445 12212744 12 20160413 0
122127445 12212744 13 20160427 20160427 0
122127445 12212744 14 20160511 20160511 0
122127445 12212744 15 20160525 20160525 0
122127445 12212744 16 20160608 20160608 0
122127445 12212744 17 20160427 20160427 0
122127445 12212744 18 20160511 20160511 0
122127445 12212744 19 20160525 20160525 0
122127445 12212744 20 20160608 20160610 0
122127445 12212744 21 20160314 20160314 0
122127445 12212744 22 20160413 0
122127445 12212744 23 20160427 20160427 0
122127445 12212744 24 20160511 20160511 0
122127445 12212744 25 20160525 20160525 0
122127445 12212744 26 20160608 20160608 0